Tag: inhalation cdmo market growth

  • Inhalation CDMO Market Overview 2024: Size, Growth Drivers, and Major Segments

    Inhalation CDMO Market Overview 2024: Size, Growth Drivers, and Major Segments

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    What is the Expected Growth Rate of the Inhalation CDMO Market from 2024 to 2033?

    The inhalation CDMO market is expected to grow from $1.94 billion in 2023 to $2.08 billion in 2024, with a CAGR of 7.1%. Key factors include the rising prevalence of respiratory disorders, demand for personalized medicine, increased outsourcing by pharmaceutical companies, and the growth of the biopharmaceutical industry.

    The inhalation CDMO market is expected to grow significantly, reaching $2.7 billion by 2028 with a CAGR of 6.8%. Growth factors include precision medicine focus, biopharmaceutical inhalation therapies, and regulatory support for drug development. Key trends involve digital health solutions, biologic inhalation therapies, and AI integration.

    Claim Your Free Sample of the Global Inhalation CDMO Market Report Today!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=13864&type=smp

    What Key Factors Are Fueling the Growth of the Inhalation CDMO Market?

    The growing prevalence of respiratory disorders is expected to drive the inhalation CDMO market. These organizations specialize in developing and manufacturing treatments for respiratory issues. Reports indicate a rise in respiratory disease-related deaths in Australia from 43,031 in 2020 to 46,551 in 2021.

    What Are the Major Segments of the Inhalation CDMO Market?

    1) By Product: Dry Powder Inhaler (DPIs), Metered Dose Inhaler (MDIs), Nebulizer, Soft Mist Inhaler

    2) By Disease Indication: Asthma, Chronic Obstructive Pulmonary Disease (COPD), Pulmonary Arterial Hypertension, Acute Respiratory Distress Syndrome, Pulmonary Fibrosis

    3) By Technology: Manual Inhalers (SMI), Digital Inhalers

    4) By End-User: Big Pharmaceutical Companies, Small and Medium-sized Pharmaceutical Companies, Generic Pharmaceutical Companies, Other End-Users

    What New Trends Are Transforming the Inhalation CDMO Market?

    In the inhalation CDMO industry, companies are forming strategic partnerships for specialized drug development. For example, in May 2023, Hovione partnered with H&T Presspart to develop a Dry Powder Inhaler platform that delivers higher drug doses more efficiently.

    Order Now for Fast Delivery of Your Inhalation CDMO Market Report!

    https://www.thebusinessresearchcompany.com/report/inhalation-cdmo-global-market-report

    Which Regions Are Driving Growth in the Inhalation CDMO Market?

    North America was the largest region in the inhalation contract development and manufacturing organization (CDMO) market in 2023. The regions covered in the inhalation cdmo market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    The Inhalation CDMO Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the inhalation cdmo market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Inhalation CDMO Market Include

    1. Inhalation CDMO Market Executive Summary

    2. Inhalation CDMO Market Segments

    3. Inhalation CDMO Market Size And Template Market Growth Rate

    4. Key Inhalation CDMO Market Trends

    5. Major Inhalation CDMO Market Drivers

    ……

    25. Key Mergers And Acquisitions In The Inhalation CDMO Market

    26. Top Inhalation CDMO Companies

    27. Inhalation CDMO Market Opportunities And Strategies

    28. Inhalation CDMO Market, Conclusions And Recommendations

    29. Appendix

    Discover Related Reports by The Business Research Company:

    Breast Cancer Drugs Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/breast-cancer-drugs-global-market-report

    Cellular Immunotherapy Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/cellulars-immunotherapy-global-market-report

    Dermatitis Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/dermatitis-drugs-global-market-report

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Comprehensive Analysis On Size, Share, And Drivers Of The Inhalation CDMO Market

    Comprehensive Analysis On Size, Share, And Drivers Of The Inhalation CDMO Market

    The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

    The inhalation CDMO market has seen robust growth due to rising prevalence of respiratory disorders globally, driven by factors such as aging populations and environmental factors.

    Forecasted Growth and Major Trends

    • Market Growth Trajectory: Expected to reach $2.7 billion by 2028, growing at a CAGR of 6.8%.
    • Key Drivers: Focus on precision medicine, biopharmaceutical inhalation therapies, and regulatory support.
    • Trends: Demand for digital health solutions, sustainable inhaler technologies, AI integration, and strategic partnerships.

    Major Companies and Market Players
    Key industry players include Pfizer Inc., Merck KGaA, Lonza Group AG, and others, focusing on innovation and strategic expansions to capitalize on market opportunities.

    Strategic Collaborations Transforming Inhalation CDMO Landscape

    • Partnership Initiatives: Example with Hovione and H&T Presspart to enhance drug delivery technologies for improved efficiency.
    • Objectives: Development of new inhaler platforms to deliver higher drug doses effectively to the lungs.

    Kindeva Drug Delivery Bolsters Inhalation Formulation Expertise

    • Strategic Acquisition: Acquired iPharma Labs Inc. to strengthen capabilities in inhaled drug delivery technologies.
    • Impact: Enhances Kindeva’s position in the expanding market for inhalation therapies.

    View More On The Inhalation CDMO Market Report 2024 – https://www.thebusinessresearchcompany.com/report/inhalation-cdmo-global-market-report

    Market Segmentation

    1. By Product:
      • Dry Powder Inhaler (DPIs)
      • Metered Dose Inhaler (MDIs)
      • Nebulizer
      • Soft Mist Inhaler
    2. By Disease Indication:
      • Asthma
      • Chronic Obstructive Pulmonary Disease (COPD)
      • Pulmonary Arterial Hypertension
      • Acute Respiratory Distress Syndrome
      • Pulmonary Fibrosis
    3. By Technology:
      • Manual Inhalers (SMI)
      • Digital Inhalers
    4. By End-User:
      • Big Pharmaceutical Companies
      • Small and Medium-sized Pharmaceutical Companies
      • Generic Pharmaceutical Companies
      • Other End-Users

    Regional Insights
    North America led the market in 2023, driven by strong pharmaceutical infrastructure and increasing investments in advanced drug delivery technologies.

    In conclusion, the inhalation CDMO market is poised for significant growth, fueled by rising respiratory disorders and advancements in drug delivery technologies. Strategic partnerships and acquisitions are shaping the competitive landscape, enhancing capabilities to meet growing demand for personalized and efficient inhalation therapies worldwide.

    Request A Sample Of The Global Inhalation CDMO Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=13864&type=smp